There is a particular kind of self-consciousness that comes from pointing a model you built yourself at a company everyone you know has an opinion on. It is not the self-consciousness of being wrong, exactly. It is the awareness of finding out that the model and the market disagree, and having to decide which one you actually believe.
I built Argos over the last several months for reasons I have written about elsewhere. The short version is that single-point valuation has always struck me as a polite fiction. A discounted cash flow produces one share price. A peer multiple produces another. An analyst target produces a third. Each of them is a slice of the future presented as if it were the picture. The honest description of any equity valuation is that you are pricing a probability distribution and pretending it is a number. Argos, true to the hundred-eyed metaphor I borrowed for it, tries to look at the distribution.
The justification for this much machinery is not that any single name deserves it. It is that the machinery only has to be built once. After that, it asks the same set of questions about every company you feed into it. The discipline of mechanical consistency is undervalued in an industry where most analysts run a different model for every ticker and call the inconsistency judgment.
Why Apple, and why now
There were two reasons to start with Apple. The first is that a verdict on a company nobody knows tells you nothing about whether the verdict is any good. If I say the model produces a sensible valuation for, say, a mid-cap Italian industrial that two of my readers have heard of, the response is going to be a polite nod. If the model produces a verdict on Apple, the response is going to be either agreement, which is interesting, or disagreement, which is more interesting still. A flagship name is a stress test for the user, not just the model.
The second reason is timing. Apple prints fiscal Q1 on Thursday. That gives the call a real expiration date. The model says what it says today, the market says what it says today, and on Friday we will all know slightly more than we did this morning about which of us was closer. Posting a valuation note three weeks before earnings is leisurely. Posting it three days before is a small commitment device.
So: AppleSpot is $266.89. The Argos call is HOLD with negative bias. The Monte Carlo base case is $215.41, which is nineteen percent below the market. Eighty-two percent of the ten thousand and one simulated paths trade below today’s price. The bottom-up DCF sanity check lands at $239.19, ten percent below market. The deterministic single path and the distribution median bracket each other within twenty-four dollars, which is the kind of agreement that makes you trust the calibration. The sell-side mean target is $297.71.
The first thing to notice is what the call is not. It is not a claim that Apple is broken. Return on invested capital exceeds the cost of capital by seven percentage points across the seven-year forecast. Net debt is thirty cents on the dollar of EBITDA. Distress probability is zero in every year of the simulation. The buyback is funded out of free cash flow at a hundred and ten billion a year. None of these are the numbers of a company in trouble. The thesis is not that the franchise is impaired.
The thesis is that the price already reflects the franchise.ShareThe disagreement is the shape, not the slope
This is the part that took me the longest to articulate clearly, and it is the part I think most short-form summaries get wrong, including, I will admit, the first version of my own LinkedIn post on the same topic.
The Street has Apple growing twelve percent in fiscal 2026 and seven percent in fiscal 2027. Argos has Apple growing roughly ten percent in fiscal 2026 and five percent in fiscal 2027. In Year One, the gap is around two hundred basis points. That is not enormous. Reasonable people can disagree about Year One revenue growth by two hundred basis points without either of them being foolish.
The disagreement is what happens after Year One.
In the Argos path, growth decays toward a revenue-weighted segment blend of about four point eight percent. The decay is not a forecast in the usual sense. It is the consequence of the Ornstein-Uhlenbeck dynamics on the cost-ratio side and the Bayesian shrinkage on the drift side, both of which pull the model toward the long-run prior at a rate determined by the data, not by the analyst. The long-run prior is itself a weighted average of segment-level priors, and those priors are anchored on what each segment has actually done over the last decade adjusted for what nominal GDP can support. Americas at four percent, Europe at four and a half, Greater China at two, Japan at two, Rest of Asia Pacific at six. None of these is heroic. None of these is conservative. They are what the data says.
The Street’s path stays elevated. To sustain twelve percent in 2026 and seven percent in 2027, the implicit segment math requires growth above the highest single-segment prior in the model, applied across the whole portfolio. This is arithmetically possible. It is also a strong claim that requires every segment to outperform its own historical prior simultaneously, which is the sort of thing you would want a reason for, and the reason offered is generally Apple Intelligence.
I do not have a strong view on whether Apple Intelligence is transformational or incremental. I do have a view that the price as of this morning is paying for transformational, and the cost of being wrong about that is wider than the cost of being wrong about, say, Greater China stabilization, which is the other live debate.
The shape of the distribution
The other thing the model insists on is that the median is not the only number on the table. The tenth percentile of the simulation is one hundred and sixty dollars. The ninetieth percentile is two hundred and eighty-nine dollars. Spot sits between the seventy-fifth and the ninetieth percentile. It is high in the distribution. It is not above it.
This matters because the actionable signal is asymmetric placement, not the gap between the median and the spot. A point estimate of $215 against a market of $267 sounds like a strong sell. A distribution that places the market in its upper third with no path going to zero in seven years is a different story. The honest framing is that the equity is priced near the upper edge of a wide central tendency in a name where the underlying franchise is intact and the catalysts that would close the gap are dated to the next twelve months. The triggers fall out of the geometry: trim above $290, hold between $200 and $290, accumulate below $200. That is not a recommendation in the regulated sense. It is what the distribution looks like.Leave a commentWhat I am actually testing
I said in the original Argos piece that two tickers would pass through the engine in public, and only two. The point is to put the model in front of an audience and take pushback, not to launch a research note service. There are plenty of those already, written by people who do this for a living and who have compliance departments to keep them honest. I have neither.
What I am testing, more specifically, is whether the model produces verdicts that an experienced reader looks at and finds defensible, even where they disagree. A model that everyone disagrees with is broken. A model that everyone agrees with is sycophantic. The interesting middle ground is a model that produces a result a reader would not have produced themselves but can reconstruct the reasoning for. Whether Argos sits in that middle ground is something I cannot evaluate from inside my own head.
So that is the actual ask. Not whether the call on Apple is right, which time will settle without my help. Whether the way Argos got to the call is the kind of reasoning you would want a model to do.
The second ticker will be the last. Suggestions in the comments.
This piece does not constitute investment research, financial advice, or a recommendation to buy, sell, or hold any security. It is shared for educational and illustrative purposes only, to demonstrate the Argos valuation engine. Information is believed accurate but is not guaranteed, and forward-looking estimates rely on assumptions that may not hold. Modeled outcomes, including Monte Carlo distributions and price triggers, are not indicative of future results and should not be relied upon as the basis for any investment decision. Readers should conduct their own due diligence and consult a licensed financial advisor before transacting in any security.
I built Argos over the last several months for reasons I have written about elsewhere. The short version is that single-point valuation has always struck me as a polite fiction. A discounted cash flow produces one share price. A peer multiple produces another. An analyst target produces a third. Each of them is a slice of the future presented as if it were the picture. The honest description of any equity valuation is that you are pricing a probability distribution and pretending it is a number. Argos, true to the hundred-eyed metaphor I borrowed for it, tries to look at the distribution.
The justification for this much machinery is not that any single name deserves it. It is that the machinery only has to be built once. After that, it asks the same set of questions about every company you feed into it. The discipline of mechanical consistency is undervalued in an industry where most analysts run a different model for every ticker and call the inconsistency judgment.
Why Apple, and why now
There were two reasons to start with Apple. The first is that a verdict on a company nobody knows tells you nothing about whether the verdict is any good. If I say the model produces a sensible valuation for, say, a mid-cap Italian industrial that two of my readers have heard of, the response is going to be a polite nod. If the model produces a verdict on Apple, the response is going to be either agreement, which is interesting, or disagreement, which is more interesting still. A flagship name is a stress test for the user, not just the model.
The second reason is timing. Apple prints fiscal Q1 on Thursday. That gives the call a real expiration date. The model says what it says today, the market says what it says today, and on Friday we will all know slightly more than we did this morning about which of us was closer. Posting a valuation note three weeks before earnings is leisurely. Posting it three days before is a small commitment device.
So: AppleSpot is $266.89. The Argos call is HOLD with negative bias. The Monte Carlo base case is $215.41, which is nineteen percent below the market. Eighty-two percent of the ten thousand and one simulated paths trade below today’s price. The bottom-up DCF sanity check lands at $239.19, ten percent below market. The deterministic single path and the distribution median bracket each other within twenty-four dollars, which is the kind of agreement that makes you trust the calibration. The sell-side mean target is $297.71.
The first thing to notice is what the call is not. It is not a claim that Apple is broken. Return on invested capital exceeds the cost of capital by seven percentage points across the seven-year forecast. Net debt is thirty cents on the dollar of EBITDA. Distress probability is zero in every year of the simulation. The buyback is funded out of free cash flow at a hundred and ten billion a year. None of these are the numbers of a company in trouble. The thesis is not that the franchise is impaired.
The thesis is that the price already reflects the franchise.ShareThe disagreement is the shape, not the slope
This is the part that took me the longest to articulate clearly, and it is the part I think most short-form summaries get wrong, including, I will admit, the first version of my own LinkedIn post on the same topic.
The Street has Apple growing twelve percent in fiscal 2026 and seven percent in fiscal 2027. Argos has Apple growing roughly ten percent in fiscal 2026 and five percent in fiscal 2027. In Year One, the gap is around two hundred basis points. That is not enormous. Reasonable people can disagree about Year One revenue growth by two hundred basis points without either of them being foolish.
The disagreement is what happens after Year One.
In the Argos path, growth decays toward a revenue-weighted segment blend of about four point eight percent. The decay is not a forecast in the usual sense. It is the consequence of the Ornstein-Uhlenbeck dynamics on the cost-ratio side and the Bayesian shrinkage on the drift side, both of which pull the model toward the long-run prior at a rate determined by the data, not by the analyst. The long-run prior is itself a weighted average of segment-level priors, and those priors are anchored on what each segment has actually done over the last decade adjusted for what nominal GDP can support. Americas at four percent, Europe at four and a half, Greater China at two, Japan at two, Rest of Asia Pacific at six. None of these is heroic. None of these is conservative. They are what the data says.
The Street’s path stays elevated. To sustain twelve percent in 2026 and seven percent in 2027, the implicit segment math requires growth above the highest single-segment prior in the model, applied across the whole portfolio. This is arithmetically possible. It is also a strong claim that requires every segment to outperform its own historical prior simultaneously, which is the sort of thing you would want a reason for, and the reason offered is generally Apple Intelligence.
I do not have a strong view on whether Apple Intelligence is transformational or incremental. I do have a view that the price as of this morning is paying for transformational, and the cost of being wrong about that is wider than the cost of being wrong about, say, Greater China stabilization, which is the other live debate.
The shape of the distribution
The other thing the model insists on is that the median is not the only number on the table. The tenth percentile of the simulation is one hundred and sixty dollars. The ninetieth percentile is two hundred and eighty-nine dollars. Spot sits between the seventy-fifth and the ninetieth percentile. It is high in the distribution. It is not above it.
This matters because the actionable signal is asymmetric placement, not the gap between the median and the spot. A point estimate of $215 against a market of $267 sounds like a strong sell. A distribution that places the market in its upper third with no path going to zero in seven years is a different story. The honest framing is that the equity is priced near the upper edge of a wide central tendency in a name where the underlying franchise is intact and the catalysts that would close the gap are dated to the next twelve months. The triggers fall out of the geometry: trim above $290, hold between $200 and $290, accumulate below $200. That is not a recommendation in the regulated sense. It is what the distribution looks like.Leave a commentWhat I am actually testing
I said in the original Argos piece that two tickers would pass through the engine in public, and only two. The point is to put the model in front of an audience and take pushback, not to launch a research note service. There are plenty of those already, written by people who do this for a living and who have compliance departments to keep them honest. I have neither.
What I am testing, more specifically, is whether the model produces verdicts that an experienced reader looks at and finds defensible, even where they disagree. A model that everyone disagrees with is broken. A model that everyone agrees with is sycophantic. The interesting middle ground is a model that produces a result a reader would not have produced themselves but can reconstruct the reasoning for. Whether Argos sits in that middle ground is something I cannot evaluate from inside my own head.
So that is the actual ask. Not whether the call on Apple is right, which time will settle without my help. Whether the way Argos got to the call is the kind of reasoning you would want a model to do.
The second ticker will be the last. Suggestions in the comments.
This piece does not constitute investment research, financial advice, or a recommendation to buy, sell, or hold any security. It is shared for educational and illustrative purposes only, to demonstrate the Argos valuation engine. Information is believed accurate but is not guaranteed, and forward-looking estimates rely on assumptions that may not hold. Modeled outcomes, including Monte Carlo distributions and price triggers, are not indicative of future results and should not be relied upon as the basis for any investment decision. Readers should conduct their own due diligence and consult a licensed financial advisor before transacting in any security.
